Comparison of Effects of Injectable Semaglutide and Dulaglutide on Oxidative Stress and Glucose Variability in Patients with Type 2 Diabetes Mellitus: A Prospective Preliminary Study
出版年份 2023 全文链接
标题
Comparison of Effects of Injectable Semaglutide and Dulaglutide on Oxidative Stress and Glucose Variability in Patients with Type 2 Diabetes Mellitus: A Prospective Preliminary Study
作者
关键词
-
出版物
Diabetes Therapy
Volume -, Issue -, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2023-10-26
DOI
10.1007/s13300-023-01493-3
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Injectable semaglutide and reductions in HbA1c and weight in the real world in people switched from alternative glucagon‐like peptide‐1 receptor agonists
- (2022) Thomas S. J. Crabtree et al. DIABETES OBESITY & METABOLISM
- Comparison of the injection‐site experience of semaglutide in a single‐dose and a multidose pen‐injector
- (2022) Søren Snitker et al. DIABETES OBESITY & METABOLISM
- Real-world use of once-weekly semaglutide in patients with type 2 diabetes: pooled analysis of data from four SURE studies by baseline characteristic subgroups
- (2022) Jean-François Yale et al. BMJ Open Diabetes Research & Care
- Effects of omarigliptin on glucose variability and oxidative stress in type 2 diabetes patients: A prospective study
- (2021) Makoto Ohara et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- 6. Glycemic Targets: Standards of Medical Care in Diabetes—2022
- (2021) DIABETES CARE
- 9. Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes—2022
- (2021) DIABETES CARE
- Effect of Dulaglutide Versus Liraglutide on Glucose Variability, Oxidative Stress, and Endothelial Function in Type 2 Diabetes: A Prospective Study
- (2019) Hiroe Nagaike et al. Diabetes Therapy
- Anti-atherogenic effects of liraglutide in hyperglycemic apolipoprotein E-null mice via AMP-activated protein kinase independent mechanisms
- (2019) Masakazu Koshibu et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- Effect of Once-Weekly Dulaglutide on Glucose Levels in Japanese Patients with Type 2 Diabetes: Findings from a Phase 4, Randomized Controlled Trial
- (2019) Megumi Inoue et al. Diabetes Therapy
- Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial
- (2019) Hertzel C Gerstein et al. LANCET
- Assessing patient PREFERence between the dulaglutide pen and the semaglutide pen: A crossover study (PREFER)
- (2019) Louis S. Matza et al. DIABETES OBESITY & METABOLISM
- Improvements of ambient hyperglycemia and glycemic variability are associated with reduction in oxidative stress for patients with type 2 diabetes
- (2018) Makoto Ohara et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Semaglutide versus dulaglutide once weekly in patients with type 2 diabetes (SUSTAIN 7): a randomised, open-label, phase 3b trial
- (2018) Richard E Pratley et al. Lancet Diabetes & Endocrinology
- Impact on HbA1c and body weight of switching from other GLP-1 receptor agonists to semaglutide: A model-based approach
- (2018) Rune V. Overgaard et al. DIABETES OBESITY & METABOLISM
- Improvement in treatment satisfaction after switching from liraglutide to dulaglutide in patients with type 2 diabetes: A randomized controlled trial
- (2018) Takahiro Takase et al. Journal of Diabetes Investigation
- Mortality and Cardiovascular Disease in Type 1 and Type 2 Diabetes
- (2017) Aidin Rawshani et al. NEW ENGLAND JOURNAL OF MEDICINE
- Impact of teneligliptin on oxidative stress and endothelial function in type 2 diabetes patients with chronic kidney disease: a case–control study
- (2016) Masaaki Sagara et al. Cardiovascular Diabetology
- Toward Defining the Threshold Between Low and High Glucose Variability in Diabetes
- (2016) Louis Monnier et al. DIABETES CARE
- Relationship between daily and day-to-day glycemic variability and increased oxidative stress in type 2 diabetes
- (2016) Makoto Ohara et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes
- (2016) Steven P. Marso et al. NEW ENGLAND JOURNAL OF MEDICINE
- GLP-1 Receptor Activation Modulates Appetite- and Reward-Related Brain Areas in Humans
- (2014) L. van Bloemendaal et al. DIABETES
- Relationship between fluctuations in glucose levels measured by continuous glucose monitoring and vascular endothelial dysfunction in type 2 diabetes mellitus
- (2013) Keiichi Torimoto et al. Cardiovascular Diabetology
- Glucagon-Like Peptide 1 Reduces Endothelial Dysfunction, Inflammation, and Oxidative Stress Induced by Both Hyperglycemia and Hypoglycemia in Type 1 Diabetes
- (2013) A. Ceriello et al. DIABETES CARE
- Prognostic implications of surrogate markers of atherosclerosis in low to intermediate risk patients with Type 2 Diabetes
- (2012) Kui-Kai Lau et al. Cardiovascular Diabetology
- GLP-1 analog liraglutide protects against oxidative stress and albuminuria in streptozotocin-induced diabetic rats via protein kinase A-mediated inhibition of renal NAD(P)H oxidases
- (2012) Hari Hendarto et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Association of glycemic variability and the presence and severity of coronary artery disease in patients with type 2 diabetes
- (2011) Gong Su et al. Cardiovascular Diabetology
- Short-term effects of liraglutide on visceral fat adiposity, appetite, and food preference: a pilot study of obese Japanese patients with type 2 diabetes
- (2011) Kana Inoue et al. Cardiovascular Diabetology
- Liraglutide Narrows the Range of Circadian Glycemic Variations in Japanese Type 2 Diabetes Patients and Nearly Flattens These Variations in Drug-Naive Type 2 Diabetes Patients: A Continuous Glucose Monitoring–Based Study
- (2011) Yutaka Mori et al. Diabetes Technology & Therapeutics
- Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies
- (2010) The Emerging Risk Factors Collaboration LANCET
- Oscillating Glucose Is More Deleterious to Endothelial Function and Oxidative Stress Than Mean Glucose in Normal and Type 2 Diabetic Patients
- (2008) A. Ceriello et al. DIABETES
- Intensive Blood Glucose Control and Vascular Outcomes in Patients with Type 2 Diabetes
- (2008) NEW ENGLAND JOURNAL OF MEDICINE
- Effects of Intensive Glucose Lowering in Type 2 Diabetes
- (2008) NEW ENGLAND JOURNAL OF MEDICINE
- 10-Year Follow-up of Intensive Glucose Control in Type 2 Diabetes
- (2008) Rury R. Holman et al. NEW ENGLAND JOURNAL OF MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More